Weight Loss Injections While Breastfeeding: What You Need to Know

Tirzepatide (Mounjaro) and semaglutide (Wegovy) are not licensed or recommended for use while breastfeeding — this is consistent across their UK Summary of Product Characteristics.
It is not known whether these medicines pass into breast milk or what effect they might have on a nursing infant; absence of data is itself a reason for caution.
Women who are breastfeeding and considering weight management support should discuss timing with their GP or a clinician before making any changes.
Contraception advice matters too: MHRA guidance recommends using contraception while on GLP-1 medicines and for a wash-out period before trying to conceive.

Weight loss injections such as Mounjaro and Wegovy are not recommended while breastfeeding. Neither tirzepatide nor semaglutide has been studied in breastfeeding women, and current UK guidance advises stopping before starting either medicine. This applies whether you are fully breastfeeding, mixed feeding, or winding down. A prescriber or GP should guide your timing and next steps. As prescription-only medicines, both require a clinical assessment before any supply — and suitability during the postpartum period is something only a clinician can properly assess for you.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

The full picture on GLP-1 weight loss injections and breastfeeding

Are weight loss injections safe while breastfeeding, what does the evidence actually say?

The honest answer is that we don't know, because breastfeeding women were excluded from the clinical trials that brought Mounjaro and Wegovy to market. SURMOUNT-1, the large tirzepatide weight-management trial published in the New England Journal of Medicine, enrolled adults with obesity and excluded pregnant or lactating participants as standard. The same is true of the STEP 1 semaglutide trial. That exclusion is normal research practice, but it means there are no human data on how much of the drug passes into breast milk, what concentration an infant would receive, or what the developmental effects might be.

UK regulators have drawn a clear line from that data gap. The Summary of Product Characteristics for both Mounjaro and Wegovy (the documents that define how these medicines are legally prescribed in the UK) state that use during breastfeeding is not recommended. The NHS medicines page for tirzepatide reflects this directly. Animal studies with tirzepatide did find drug-related effects in offspring, which adds to the caution even though animal data cannot be mapped directly onto humans.

So if you are asking whether you can take weight loss injections while breastfeeding: the clinical position is no, not currently. This is not a caveat buried in small print, it is the mainstream UK medical recommendation. If you want more context on GLP-1 injections in general, our overview of weight loss injections covers the licensed options and how they work.

What happens when you stop breastfeeding, can you start then?

Stopping breastfeeding does not automatically mean you can start a weight loss injection the next day. There are two things to think through with a clinician: wash-out timing and contraception.

On timing, neither the tirzepatide nor semaglutide SmPC specifies an exact breastfeeding cessation interval in the way some medicines do. That means the decision on when it is appropriate to begin treatment rests with the prescribing clinician, who will consider the length of your breastfeeding journey, any mixed-feeding history, your overall health and your goals. It is not a decision to make based on a forum post or a general guide.

On contraception, the picture is concrete. The MHRA and NHS England's guidance on weight management injections both advise using reliable contraception while on these medicines and for a period afterwards before trying to conceive again. For tirzepatide specifically, women taking oral contraceptives should add a non-oral method (condoms, for example) for the first four weeks of treatment and for four weeks after each dose increase, because the pill's absorption may be reduced while gastric emptying is slower. Semaglutide does not carry the same evidence-based interaction with the pill, but contraception is still advised. A clinician can help you choose the right method for your circumstances.

Once you are ready to explore your options, our guide to getting weight loss injections through a registered UK pharmacy explains the process for a private prescription route.

What weight management support is available while you are still breastfeeding?

Weight loss injections are off the table while you are breastfeeding, but that does not mean nothing can be done. A few points worth knowing.

Postpartum weight management through diet and activity is well-supported by evidence and carries no risk to your infant. NHS Better Health's weight guidance is a reasonable starting point for evidence-based lifestyle advice during this period. Calorie intake needs to stay adequate while breastfeeding (this is not the moment for a sharp deficit) so working with a GP or dietitian on a sustainable approach is wise.

Orlistat, a lipase inhibitor available at lower doses without a prescription, is also not recommended during breastfeeding and would need a clinical review regardless. There is no licensed weight management medicine in the UK that has been cleared for use in breastfeeding women.

The practical upshot: use the breastfeeding period to establish healthy patterns, talk to your GP about your longer-term goals, and plan ahead so that when the time is right you have a clear route. Our dedicated guide to weight loss injections and breastfeeding goes into further detail on what treatment might look like afterwards, including the consultation process and what actually arrives (your pen ships in a plain, unbranded box via tracked DPD delivery once a clinician approves your prescription). You can also read about how diet works alongside these medicines so you are prepared well in advance, and if you have questions about how weight loss injections relate to breast cancer, we cover the evidence on that topic too.

Who should you talk to, and what should you ask?

Your GP is the right first call if you are postpartum and thinking about weight management. They can assess where you are in your feeding journey, flag any other health factors (blood pressure, thyroid, mood) that matter at this stage, and advise on timing if you want to consider a medicine-supported approach later.

When the time comes and you are no longer breastfeeding, a clinician-led private service is an option if NHS waiting lists are long or you do not meet the current NHS eligibility criteria, which are phased and relatively strict. At nume, every consultation is personally read by a GPhC-registered Independent Prescriber, not processed by software. That review happens the same day. Questions about what to expect from the process are answered on our FAQs page, and if something comes up that needs a direct conversation, our team is reachable via the contact page.

If you are currently not breastfeeding and are ready to find out whether treatment might be appropriate for you, you can start your free consultation today.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions